Photoelectric and epigenetic test for cervical cancer screening
Part of Cancer, Women’s health & pregnancy clinical trials.
This study is testing a new, non-invasive way to screen for cervical cancer using light-based detection and epigenetic analysis. It may help find high-risk changes earlier and more accurately than current methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 65 and have had sexual intercourse
- Your HPV test shows types 16 or 18, or a high-risk type with an abnormal Pap smear (ASC-US or worse)
- You have not had cervical cancer or cervical surgery (like conization, ablation, or photodynamic therapy)
- You are not currently menstruating, and you have not had sex or used vaginal creams in the last 48 hours
- You do not have acute inflammation of the vagina or cervix
- You are not pregnant or recently postpartum, and you do not have a weak immune system or bleeding disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a light-based treatment (photodynamic therapy) for high-grade cervical precancerous changes, which may avoid the need for immediate surgery. It compares this approach to standard surgery to see if it is safe and effective.
This study tests a new technology to help find cervical cancer earlier by focusing on people who already had an abnormal screening result. It may help improve how abnormal tests are checked and diagnosed.
This trial is testing a new, low-cost, lab-free screening test for cervical cancer. The goal is to see if it can detect early signs of cancer without needing a doctor's visit or a lab — making it easier for women to get screened.
This study tests whether special light-based scans (optical spectroscopy) can help detect cervical cancer. It may be done around colposcopy, and participants may also be monitored with follow-up Pap smears after treatment.
This study tests a new questionnaire that may help doctors better identify which women need treatment for cervical changes. It is for women who have had an abnormal Pap smear or a positive HPV test and are going for a colposcopy (a closer look at the cervix).
This trial tests a new way to quickly diagnose and treat cervical pre-cancer using a point-of-care device. It may help women who are HPV-positive avoid a separate treatment visit.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.